166 related articles for article (PubMed ID: 19881537)
1. c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma.
Scheller H; Tobollik S; Kutzera A; Eder M; Unterlehberg J; Pfeil I; Jungnickel B
Oncogene; 2010 Feb; 29(6):888-97. PubMed ID: 19881537
[TBL] [Abstract][Full Text] [Related]
2. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
Seifert M; Küppers R
Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
[TBL] [Abstract][Full Text] [Related]
3. High levels of AID cause strand bias of mutations at A versus T in Burkitt's lymphoma cells.
Kano C; Wang JY
Mol Immunol; 2013 Jul; 54(3-4):397-402. PubMed ID: 23399385
[TBL] [Abstract][Full Text] [Related]
4. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
5. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma.
Vincent C; Truffinet V; Fiancette R; Petit B; Cogné N; Cogné M; Denizot Y
Biochim Biophys Acta; 2009 Feb; 1793(2):418-26. PubMed ID: 19026697
[TBL] [Abstract][Full Text] [Related]
6. AID-targeting and hypermutation of non-immunoglobulin genes does not correlate with proximity to immunoglobulin genes in germinal center B cells.
Gramlich HS; Reisbig T; Schatz DG
PLoS One; 2012; 7(6):e39601. PubMed ID: 22768095
[TBL] [Abstract][Full Text] [Related]
7. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
[TBL] [Abstract][Full Text] [Related]
8. Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: differential regulation in B cell lines derived from endemic or sporadic Burkitt's lymphoma.
Salamon D; Adori M; He M; Bönelt P; Severinson E; Kis LL; Wu L; Ujvari D; Leveau B; Nagy N; Klein G; Klein E
Cytokine; 2012 Mar; 57(3):360-71. PubMed ID: 22204827
[TBL] [Abstract][Full Text] [Related]
9. Establishment of the novel B acute lymphoblastic leukemia (FAB L3) cell line KHM-10B with a 13q34 abnormality and constitutive expression of c-myc and max during cell cycle.
Sonoki T; Matsuzaki H; Miyamoto K; Taniwaki M; Yoshino T; Hata H; Yoshida M; Matsuno F; Nagasaki A; Kuribayashi N
Leukemia; 1995 Dec; 9(12):2093-9. PubMed ID: 8609722
[TBL] [Abstract][Full Text] [Related]
10. Id2 is dispensable for myc-induced lymphomagenesis.
Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL
Cancer Res; 2004 Oct; 64(20):7296-301. PubMed ID: 15492249
[TBL] [Abstract][Full Text] [Related]
11. Burkitt lymphomagenesis linked to MYC plus PI3K in germinal center B cells.
Sander S; Rajewsky K
Oncotarget; 2012 Oct; 3(10):1066-7. PubMed ID: 23164662
[No Abstract] [Full Text] [Related]
12. GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo.
Healy JA; Nugent A; Rempel RE; Moffitt AB; Davis NS; Jiang X; Shingleton JR; Zhang J; Love C; Datta J; McKinney ME; Tzeng TJ; Wettschureck N; Offermanns S; Walzer KA; Chi JT; Rasheed SA; Casey PJ; Lossos IS; Dave SS
Blood; 2016 Jun; 127(22):2723-31. PubMed ID: 26989201
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression.
Suk FM; Lin SY; Lin RJ; Hsine YH; Liao YJ; Fang SU; Liang YC
Oncotarget; 2015 Sep; 6(28):25988-6001. PubMed ID: 26317903
[TBL] [Abstract][Full Text] [Related]
14. AID is required for germinal center-derived lymphomagenesis.
Pasqualucci L; Bhagat G; Jankovic M; Compagno M; Smith P; Muramatsu M; Honjo T; Morse HC; Nussenzweig MC; Dalla-Favera R
Nat Genet; 2008 Jan; 40(1):108-12. PubMed ID: 18066064
[TBL] [Abstract][Full Text] [Related]
15. Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.
Sander S; Calado DP; Srinivasan L; Köchert K; Zhang B; Rosolowski M; Rodig SJ; Holzmann K; Stilgenbauer S; Siebert R; Bullinger L; Rajewsky K
Cancer Cell; 2012 Aug; 22(2):167-79. PubMed ID: 22897848
[TBL] [Abstract][Full Text] [Related]
16. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the IGHV region in Burkitt's lymphomas supports a germinal center origin and a role for superantigens in lymphomagenesis.
Baptista MJ; Calpe E; Fernandez E; Colomo L; Cardesa-Salzmann TM; Abrisqueta P; Bosch F; Crespo M
Leuk Res; 2014 Apr; 38(4):509-15. PubMed ID: 24480549
[TBL] [Abstract][Full Text] [Related]
18. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Bemark M; Neuberger MS
Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
[TBL] [Abstract][Full Text] [Related]
19. EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells.
Boccellato F; Anastasiadou E; Rosato P; Kempkes B; Frati L; Faggioni A; Trivedi P
J Virol; 2007 Mar; 81(5):2274-82. PubMed ID: 17151114
[TBL] [Abstract][Full Text] [Related]
20. Nuclear FOXO1 promotes lymphomagenesis in germinal center B cells.
Kabrani E; Chu VT; Tasouri E; Sommermann T; Baßler K; Ulas T; Zenz T; Bullinger L; Schultze JL; Rajewsky K; Sander S
Blood; 2018 Dec; 132(25):2670-2683. PubMed ID: 30333121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
